Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars
Starting soon · Not applicable
Conditions studied: Pulp Disease, Dental, Pulp Therapy in Primary Molars, Pulpitis - Reversible, Pulp Inflammation, Vital Pulp Therapies, Carious Exposure of Pulp, Primary Molar Tooth, Primary Molar Pulpotomy
In brief
This study aims to evaluate clinical and radiographic success of oxymetazoline versus sodium hypochlorite as hemostatic agents in MTA pulpotomy of primary molars.
Key facts
- Study ID
- NCT07675330
- Run by
- Cairo University
- People needed
- 50
- Starts
- 2026-08-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-06-30
Who can join
Age: 4 and older, up to 8. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients: Egyptian children with carious mandibular primary molars aged 4-8 years.
- Teeth: Restorable mandibular primary molars with no clinical signs or symptoms of irreversible pulpitis.
- Pre-operative Radiograph: No radiographic signs of internal or external root resorption and no furcation or periapical radiolucencies.
You may not qualify if…
- • Patients:
- Uncooperative children.
- Medically compromised children.
- Patients whose parents refuse to participate or refuse to sign the informed consent.
- Teeth:
- <!-- -->
- Previously accessed molars.
- Mobile primary molars.
- Presence of sinus tract or pain on percussion.
Where it is running
- Faculty of dentistry, Cairo University. — Cairo, Egypt
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.